Submitted by endpointsnews6292 in business
Sanofi was the mystery “Party A” that engaged in a bidding war with Biogen for the $7.3 billion buyout of Reata Pharmaceuticals, according to a Bloomberg News report, citing unnamed sources. The French Big Pharma bid for Reata first, but its former CEO Chris …